[Immunological studies of the cerebrospinal fluid in patients with amyotrophic lateral sclerosis]

Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)
|January 1, 1991
PubMed

Insights

This study found no significant changes in cerebrospinal fluid (CSF) immunoglobulins or proteins in patients with lateral amyotrophic sclerosis (LAS). These immunochemical markers do not aid in diagnosing LAS or understanding its pathogenesis.

Area of Science:

  • Neurology
  • Immunology
  • Biochemistry

Background:

  • Lateral amyotrophic sclerosis (LAS) is a neurodegenerative disease with complex pathogenesis.
  • Cerebrospinal fluid (CSF) analysis is crucial for understanding neurological disorders.

Purpose of the Study:

  • To investigate the concentrations of immunoglobulins and specific proteins in the CSF of LAS patients.
  • To determine if these immunochemical markers correlate with clinical status or aid in diagnosis.

Main Methods:

  • Immunochemistry techniques were employed to quantify immunoglobulins and select proteins in CSF samples.
  • CSF parameters were compared against established reference intervals.

Main Results:

  • No significant deviations from reference intervals were observed for the measured CSF immunochemical parameters.
  • No characteristic immunochemical features were identified that correlated with the clinical status of LAS patients.
  • The study parameters did not provide definitive insights into the pathogenesis or diagnosis of LAS.

Conclusions:

  • Immunochemical analysis of CSF does not currently offer a reliable diagnostic or pathogenetic marker for lateral amyotrophic sclerosis.
  • Immunologically, LAS appears distinct from other demyelinating diseases based on these findings.

Related Concept Videos